by TractManager | Aug 31, 2021 | Emerging Technology Report
The Vivistim Paired VNS System is an implanted neurostimulator system intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with...
by TractManager | Aug 26, 2021 | Emerging Technology Report
Mitapivat is an investigational oral drug designed to increase the activity of the pyruvate kinase (PK) enzyme in red blood cells. It is proposed for the treatment adults with PK deficiency. If you have a Hayes login, click here to view the full report on the...
by TractManager | Aug 25, 2021 | Emerging Technology Report
Donanemab is an intravenously administered amyloid beta-directed antibody proposed for the treatment of Alzheimer disease.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Aug 24, 2021 | Emerging Technology Report
The HistoSonics System is an ultrasound histotripsy system intended for noninvasive mechanical destruction of malignant cells via acoustic cavitation. It is under investigation for the treatment of primary or metastatic hepatocellular tumors. If you have a Hayes...
by TractManager | Aug 17, 2021 | Emerging Technology Report
Oportuzumab monatox is an antibody-drug conjugate that targets epithelial cell-adhesion molecule (EpCAM) in development for the treatment of bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer. It is an intravesical treatment, administered through...
Recent Comments